Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 0.7100
-0.0120 (-1.66%)
Oct 30, 2025, 1:30 PM CET
Sequana Medical NV Revenue
In the year 2024, Sequana Medical NV had annual revenue of 105.50K EUR, down -85.19%.
Revenue
105.50K
Revenue Growth
-85.19%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
43.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 105.50K | -606.67K | -85.19% |
| Dec 31, 2023 | 712.17K | -210.51K | -22.82% |
| Dec 31, 2022 | 922.69K | 552.19K | 149.04% |
| Dec 31, 2021 | 370.50K | -592.78K | -61.54% |
| Dec 31, 2020 | 963.28K | -7.36K | -0.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 6.85B |
| argenx SE | 2.66B |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| European Medical Solutions | 49.47M |
| Biocartis Group NV | 47.69M |
| Hyloris Pharmaceuticals | 8.46M |
| Nyxoah | 4.93M |
Sequana Medical NV News
- 8 months ago - Sequana Medical NV GAAP EPS of -€1.22, revenue of €0.106M - Seeking Alpha